Thromboelastography During Surgery for Malignant Pleural Mesothelioma

Status unconfirmed

Conditions studied: Coagulopathy, Mesothelioma

In brief

Surgery for malignant pleural mesothelioma is complex and prolonged, and may involve significant blood loss with considerable blood and product transfusion. Thromboelastography (TEG) is a global assay of coagulation that uses whole blood to produce a tracing that records kinetic changes in clot formation. This study aims provide a better understanding of the coagulation profile of these patients, and will form the basis of a TEG-based transfusion algorithm for future surgeries for mesothelioma.

Key facts

Study ID

NCT01912547

Run by

Brigham and Women's Hospital

People needed

100

Starts

2013-09-01

Expected to finish

2015-12-01

Last updated by the study team

2015-01-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult male or female patients undergoing elective surgery for malignant pleural mesothelioma

You may not qualify if…

• Unwilling or unable to provide consent
• History of bleeding disorder
• On medications that may affect hemostasis

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.